The U.S. Supreme Court has recently heard arguments in Association for Molecular Pathology v. Myriad Genetics, Inc, the issue being the eligibility of Myriad's patent claims to isolated DNA encoding BRCA1 polypeptides.

On September 16, 2011, President Obama signed into law the America Invents Act (AIA), which effectuated some of the most sweeping changes in the patent laws since the Patent Act of 1952.

On Wednesday, the Supreme Court unanimously reversed the Federal Circuit in Medtronic v. Mirowski Family Ventures (previously listed as Medtronic v. Boston Scientific), holding that the burden of proving infringement remains on the patent owner, even when a licensee seeks a declaratory judgment of noninfringement.

Yesterday, the U.S. Supreme Court issued its ruling in Nautilus, Inc. v. Biosig Instruments, Inc. involving the definiteness requirement of 35 U.S.C. § 112 (b).

Effective as of Sept. 26, 2011, the USPTO is accepting requests for prioritized examination that accompany any original utility or plant application filing.

Yesterday, in Petrella v. Metro-Goldwyn-Mayer, Inc. (No. 12-1315), the Supreme Court ruled that the doctrine of laches could not be invoked to bar a copyright claim...

The Court held in Alice Corp. v. CLS Bank Int’l that all the patent claims in the case were not patent eligible.

On November 18, 2011, the Court of Appeals for the Federal Circuit heard oral arguments in the en banc rehearings of the Akamai and McKesson cases.

The U.S. Court of Appeals for the Federal Circuit has recently reheard "en banc" the question whether computer-implemented business methods are eligible for a U.S. patent.

On July 29, 2011, the Federal Circuit handed down the hotly-anticipated decision in Association for Molecular Pathology v. USPTO, Fed. Cir., No. 2010-1406, 7/29/2011. In a 2-1 decision, the Panel held that isolated DNA molecules are eligible for patent protection under 35 U.S.C. § 101.

Kraft filed suit against Heartland in the U.S. District Court for the District of Delaware, alleging that Heartland's liquid water enhancer products infringe three of Kraft's patents.

The Federal Circuit heard arguments on Friday in Lighting Ballast Control LLC v. Philips Electronics North America.

The US PTO has acquiesced to the recent decision of the Federal Circuit Court of Appeals in Therasense v. Becton-Dickinson, proposing that it will adopt the Therasense standard of materiality for disclosure of information by applicants in US patent prosecution.

The U.S. Supreme Court has just issued its decision in "Kirtsaeng v. John Wiley & Sons, Inc.", and its holding could have consequences on international sales and trafficking of copyrighted goods.

The window for objecting to the approximately 1,900 new Generic Top Level Domain applications that are being considered for introduction to the Internet domain name system closes on March 13, 2013.

On April 18, 2012, the Supreme Court upheld the right of patent applicants to seek full district court review of Patent Office rejections pursuant to 35 U.S.C. § 145, before taking an appeal to the Federal Circuit.

April 23, 2014 – Yesterday, the U.S. Supreme Court heard oral arguments in "American Broadcasting Companies, et al. v. Aereo".

On March 25, 2013, the Supreme Court heard oral arguments in "Federal Trade Commission v. Actavis", which involves a circuit split regarding "pay for delay" settlements within the pharmaceutical industry.

An overview of several important provisions of the America Invents Act, which went into effect on September 16, 2012.

In the drive to reduce costs and overhead, intellectual property attorneys, and in-house counsel in particular, are increasingly asked to take on tangential areas of work.